Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.

This bill requires New Jersey nursing homes and assisted living facilities (licensed under state law) to maintain an on-site supply of COVID-19 antiviral treatments. It mandates that these facilities provide such treatment to any resident who tests positive for COVID-19 and is experiencing symptoms. The law applies directly to long-term care facilities operating in New Jersey and takes effect immediately. The requirement focuses on ensuring timely access to antiviral treatment for symptomatic residents, without specifying which antiviral drugs must be stocked.